e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Pro-Con Debate "Severe community-acquired pneumonia: a lung disease?"
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
PRO: Severity scores are useful
M. Woodhead (Manchester, United Kingdom)
Source:
Annual Congress 2012 - Pro-Con Debate "Severe community-acquired pneumonia: a lung disease?"
Session:
Pro-Con Debate "Severe community-acquired pneumonia: a lung disease?"
Session type:
Symposium
Number:
140
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Woodhead (Manchester, United Kingdom). PRO: Severity scores are useful. Annual Congress 2012 - Pro-Con Debate "Severe community-acquired pneumonia: a lung disease?"
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
CON: Severity scores are not useful
Source: Annual Congress 2012 - Pro-Con Debate "Severe community-acquired pneumonia: a lung disease?"
Year: 2012
Severity assessment tools in CAP
Source: Eur Respir Monogr 2014; 63: 88-104
Year: 2014
Severity of bronchiectasis: FACED Score vs Bronchiectasis Severity Index
Source: International Congress 2019 – Bronchiectasis
Year: 2019
Bronchiectasis Severity Index and FACED score correlation determinants
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019
From kitchen table questionnaires to valid PRO: how PRO's can provide insight in clinical events, the EXACT-PRO example
Source: Annual Congress 2012 - An ERS/ELF joint session "New tools to assess improvement in respiratory patients: capturing the patient's perspective"
Year: 2012
Post-COVID-19 Symptom Burden: What is Long-COVID and how should we manageit?
Source: Virtual Congress 2021 – Emerging evidence on sub-acute and long COVID-19
Year: 2021
The PROGRESS Study - Operationalization of Disease Severity and Prediction ofOutcome using the SOFA Score
Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Year: 2018
Severity of OSA and Depression
Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea
Year: 2019
The SAQ is a valid quality of life measure in severe asthma: the mini-AQLQ and ACQ both measure symptoms
Source: Virtual Congress 2020 – Phenotypes of obstructive diseases
Year: 2020
Implementation of a Paediatric Bronchiectasis Severity Index (PBSI)
Source: Virtual Congress 2021 – Acute and chronic lung infections in children
Year: 2021
Severity Scores used in the assessment of Bronchiolitis: A systematic review
Source: Virtual Congress 2021 – Acute and chronic lung infections in children
Year: 2021
Are ACQ scores a useful measure of severity in obese patients?
Source: Annual Congress 2013 –Disease control and quality of life in airway diseases
Year: 2013
Risk assessment scores: a critical appraisal
Source: ERS Research Seminar 2018 – Lung Cancer Screening: from Trial to Practice
Year: 2018
Proposed MID in FACIT and VAS scores for individuals attending COVID-19 rehabilitation.
Source: Virtual Congress 2021 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2021
PRO: maintenance is cost-effective
Source: Annual Congress 2012 - Pro/Con Debate "Cost-effectiveness of maintenance chemotherapy for NSCLC"
Year: 2012
The cut-off values for Visual Analogue Scale (VAS) and for the Assessment Tool for Asthma (ATA) according the Control for Asthma and Allergic Rhinitis Test (CARAT)
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021
CCQ and ACQ scores in obstructive lung disease: one questionnaire for all?
Source: International Congress 2018 – Physiological and biological insights in asthma
Year: 2018
LENT score - useful clinical tool?
Source: International Congress 2019 – Pleural disease: applying the evidence
Year: 2019
Validation of the Bronchiectasis Impact Measure (BIM): a novel patient-reported outcome measure
Source: Eur Respir J, 57 (5) 2003156; 10.1183/13993003.03156-2020
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept